Max Hodak’s Science Corp. is preparing to place its first sensor in a human brain | TechCrunch

Last day to exhibit your breakthrough to 10,000+ tech leaders at Disrupt is on Oct 2. Book Exhibit Table Now. Disrupt doors open Oct. 13. Get your pass and bring someone with you at 50% off. REGISTER NOW. Science Corporation, the startup from former Neuralink president and co-founder Max Hodak, has enlisted a top neurobiologist to lead the first U.S. human trials for its biohybrid brain-computer interface. Dr. Murat Günel, chair of Yale Medical School’s Department of Neurosurgery, has signed on as a scientific adviser after two years of discussions. His goal is to surgically place the first sensor for a future interface — one that will eventually combine lab-grown neurons with electronics — into a patient’s brain. Science, founded in 2021, completed a $230 million Series C fundraising round last month that valued the company at $1.5 billion. Its most advanced product is PRIMA, a device for restoring vision in people with blindness caused by macular degeneration and similar conditions. Science acquired the technology in 2024 and has advanced it through clinical trials, with plans to make it more widely available in Europe once regulatory approval is obtained, perhaps as soon as this

Apr 14, 2026 → Apr 28, 2026